The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis
Journal of Alzheimer’s Disease · 2024
DOI: 10.3233/jad-231080 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Jianhong Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Fujian Key Laboratory of Aptamers Technology, 900TH hospital of Joint Logistics Support Force, People's Liberation Army (PLA), Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Neurodegenerative Diseases, Cognitive Dysfunction. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Background
Alzheimer’s disease (AD) is a neurodegenerative disease with insidious onset. Identifying candidate predictors to forecast AD dementia risk before disease onset is crucial for early diagnosis and treatment.
Objective
We aimed to assess the predictive ability of blood neurofilament light (NfL) chain in anticipating cognitive decline in the AD continuum.
Methods
We systematically searched PubMed, Web of Science, and Embase from inception until April 7, 2023. Longitudinal observational studies examining the association between baseline blood NfL and cognitive decline or clinical disease conversion were included based on inclusion/exclusion criteria. The final effect size was represented by adjusted hazard ratios (HR) or standardized beta (s.β) coefficients with a 95% confidence interval (CI).
Results
A total of 2,862 articles were identified, and 26 studies were included in this meta-analysis. The results indicated that baseline blood NfL could predict cognitive decline, with MMSE [s.β= –0.17, 95% CI (–0.26, –0.07)]; PACC [s.β= –0.09, 95% CI (–0.16, –0.03)]; ADAS-cog [s.β= 0.21, 95% CI (0.13, 0.29)]; CDR-SOB [s.β= 0.27, 95% CI (0.03, 0.50)]; Global cognitive composite [s.β= –0.05, 95% CI (–0.08, –0.01)]; Memory subdomain [s.β= –0.06, 95% CI (–0.09, –0.03)]; Language subdomain [s.β= –0.07, 95% CI (–0.10, –0.05)]; Executive function subdomain [s.β= –0.02, 95% CI (–0.03, –0.01)]; Visuospatial subdomain [s.β= –0.06, 95% CI (–0.08, –0.04)]. Additionally, baseline blood NfL could predict disease progression (conversion from CU/SCD/MCI to MCI/AD) in the AD continuum [Adjust HR = 1.32, 95% CI (1.12, 1.56)].
Conclusions
Baseline blood NfL demonstrated predictive capabilities for global cognition and its memory, language, executive function, visuospatial subdomains decline in the AD continuum. Moreover, it exhibited the potential to predict disease progression in non-AD dementia participants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fujian Key Laboratory of Aptamers Technology, 900TH hospital of Joint Logistics Support Force, People's Liberation Army (PLA), Fuzhou, Fujian, China.
- National-Local Joint Engineering Research Center of Rehabilitation Medicine Technology, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
- The Institute of Rehabilitation Industry, Fujian University of Traditional Chinese Medicine, Fuzhou, Fujian, China.
Zitieren
APA
Li, J., Yang, M., Wei, R., Cao, Y., Fan, X., & Zhang, S. (2024). The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-231080
Vancouver
Li J, Yang M, Wei R, Cao Y, Fan X, Zhang S. The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-231080
BibTeX
@article{Li2024,
author = {Li, Jianhong and Yang, Minguang and Wei, Renli and Cao, Yue and Fan, Xu and Zhang, Shenghang},
title = {The Predictive Ability of Blood Neurofilament Light Chain in Predicting Cognitive Decline in the Alzheimer’s Disease Continuum: A Systematic Review and Meta-Analysis},
journal = {Journal of Alzheimer’s Disease},
year = {2024},
doi = {10.3233/jad-231080}
}
EUVIMED